Opko Health
在场
是其中之一......
Opko Health 是一家在股票代码 OPK (US) 下上市的公司。
Opko Health 拥有 3家子公司，其中包括 Bio-Reference Laboratories、ModeX Therapeutics 和 Opko Renal。
他们在：
高管
查看带有其 34 名主要高管的组织结构图
Opko Health 搜索最多的简介
- Phillip Frost, Chairman of the Board & Chief Executive Officer
- Prem Lachman, Director
- Alice Lin-Tsing Yu, Director
创建提醒
跟踪 Opko Health 的高管变动
药店
Opko Health 拥有 1,837 家竞争者，其中包括 Pfizer (美国(美洲))、Johnson & Johnson (美国(美洲)) 和 Sanofi (法国)。
Popular M&A news in 药店
- Grace Therapeutics将在Oct 24, 2024将其名称改为Grace Therapeutics。 (公布2024十月27号).
- Orasis Pharmaceuticals 刚刚宣布为 78 筹款数百万美元。 (公布2024十月21号).
- Lundbeck has announced the acquisition of Longboard Pharmaceuticals (公布2024十月17号).
药店 行业的其他推荐联系人
消息
Opko Health 的最新新闻稿
- ModeX Therapeutics Secures $35 Million BARDA Supplement to Develop COVID Multispecific Antibodies and $16 Million to Initiate Influenza Program
- OPKO Health’s ModeX Therapeutics Appoints Dr. Giovanni Abbadessa as Chief Medical Officer as Pipeline Advances into Clinical Development
- Press Releases
- Entera Bio and OPKO Health Provide Update on PK/PD Results of Oral Oxyntomodulin (GLP-1/Glucagon) Peptide Tablet Candidate for Obesity and Metabolic Disorders
- Labcorp Completes Acquisition of Select Assets of BioReference Health's Diagnostics Business from OPKO Health
- OPKO Health Reports Second Quarter 2024 Business Highlights and Financial Results
- OPKO Health Announces $100 Million Share Repurchase Program
- OPKO Health and HealthCare Royalty Enter into $250 Million Note Purchase Agreement Secured by NGENLA’s Profit Share Payments
- OPKO Health to Participate in the Jefferies Global Healthcare Conference
- OPKO Health Reports First Quarter 2024 Business Highlights and Financial Results
- View more press releases Close
关于 Opko Health 的社交媒体
保持联系
通过电子邮件联系联系该企业高管，包括 Phillip Frost 
